Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Fielmann Group AG's Net Cash per Share or its related term are showing as below:
During the past 13 years, the highest Price-to-Net-Cash Ratio of Fielmann Group AG was 360.00. The lowest was 29.80. And the median was 82.05.
XSWX:FIE's Price-to-Net-Cash is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 8.23 * Ranked among companies with meaningful Price-to-Net-Cash only.
Fielmann Group AG (XSWX:FIE) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Fielmann Group AG Net Cash per Share Related Terms
Fielmann Group AG Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FIE vs ISRG, BDX, MDLN: Net Cash per Share Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG Price-to-Net-Cash vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Fielmann Group AG's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fielmann Group AG (XSWX:FIE) has a Net Cash per Share of CHF0.00 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Fielmann Group AG and its competitors. Over the past decade, Fielmann Group AG's Net Cash per Share has ranged from 29.80 to 360.00. According to the industry distribution chart, Fielmann Group AG ranks #999999 out of 301 companies in the Medical Devices & Instruments industry.
Is Fielmann Group AG's Net Cash per Share too high?
Fielmann Group AG's current Net Cash per Share is CHF0.00. Over the past 10 years, this metric has ranged from a low of 29.80 to a high of 360.00. Based on the distribution chart, Fielmann Group AG ranks #999999 out of 301 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Fielmann Group AG has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's Net Cash per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #999999 out of 301 companies for Net Cash per Share. This places Fielmann Group AG in the lower half of its industry. The industry median Net Cash per Share is 8.23. Historically, Fielmann Group AG's own Net Cash per Share has ranged from 29.80 to 360.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Medical Devices & Instruments company?
The median Net Cash per Share among Medical Devices & Instruments companies is 8.23, based on 301 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median Net Cash per Share is 8.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current Net Cash per Share is CHF0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current Net Cash per Share of CHF0.00. The stock's GF Value™ is CHF48.76, compared to a current price of CHF38.30 — trading 21.5% below its estimated fair value. The current Net Cash per Share is CHF0.00. Fielmann Group AG's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current Net Cash per Share is CHF0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF38.30 is trading 21.5% below its estimated GF Value™ of CHF48.76.
Key valuation signals for XSWX:FIE:
Net Cash per Share: CHF0.00
GF Value™: CHF48.76 vs. price of CHF38.30 (21.5% below fair value)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
76GF Score
Get the complete analysis for XSWX:FIE
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
